Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.72+0.00 (+0.43%)
Close on Nov 18, 2026Market cap $8.37MP/E –Yield –
Phio Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Phio Pharmaceuticals's free cash flow for the twelve months ending Jun 30, 2026 was -$12.21M. For fiscal 2025 it was -$7.99M. The highest annual figure on record is -$5.08M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.99M | – |
| FY2024 | Dec 31, 2024 | -$7.11M | – |
| FY2023 | Dec 31, 2023 | -$10.75M | – |
| FY2022 | Dec 31, 2022 | -$12.25M | – |
| FY2021 | Dec 31, 2021 | -$11.91M | – |
| FY2020 | Dec 31, 2020 | -$8.82M | – |
| FY2019 | Dec 31, 2019 | -$8.72M | – |
| FY2018 | Dec 31, 2018 | -$7.53M | – |
| FY2017 | Dec 31, 2017 | -$9.72M | – |
| FY2016 | Dec 31, 2016 | -$7.76M | – |
| FY2015 | Dec 31, 2015 | -$7.37M | – |
| FY2014 | Dec 31, 2014 | -$7.85M | – |
| FY2013 | Dec 31, 2013 | -$6.39M | – |
| FY2012 | Dec 31, 2012 | -$5.08M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.00M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.08M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.09M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.28M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.37M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.78M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.71M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.44M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.57M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.90M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.27M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.98M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.54M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.05M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.95M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.18M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.75M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.01M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.86M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.91M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.21M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.80M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.37M | – |
See a number that looks wrong?